Specifically, we hypothesized that overexpression of specific PMTs or PDMTs by cancer cells may silence the transcription and expression of effector T-cell chemokines or HLA class I and APM components, leading to decreased effector T-cell trafficking and/or defective antigen presentation in SCCHN. Here, ANPEP is linked to cancer.